Not yet recruitingNot applicableNCT06728605

Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery

Studying Cardiogenic shock

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nanjing Medical University
Principal Investigator
Jun-jie Du, MD
The First Affiliated Hospital with Nanjing Medical University
Intervention
Enhanced External Counterpulsation (EECP)(device)
Enrollment
400 enrolled
Eligibility
18-80 years · All sexes
Timeline
2025 – 2025

Study locations (1)

Collaborators

The First Affiliated Hospital with Nanjing Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06728605 on ClinicalTrials.gov

Other trials for Cardiogenic shock

Additional recruiting or active studies for the same condition.

See all trials for Cardiogenic shock →

← Back to all trials